A multi-generational family gathers in a brightly lit kitchen to prepare breast fast.

الموارد = نتائج أفضل

Genetic Testing

قد يكون الاختبار الجيني خيارًا لأولئك الذين يريدون المزيد من المعلومات حول خطر الإصابة بالسرطان بناءً على تاريخ العائلة أو العرق/الإثنية.

Genetic testing involves looking for changes in a person’s genes, called mutations (or variants), that impact risk and could be found before any other signs of a disease. These mutations are inherited from a parent and carry different risks for cancer based on the specific mutation. Genetic testing can be performed by testing a person’s blood or saliva to identify whether they have inherited a genetic mutation in one of these genes.

There are many types of mutations that can be identified through genetic testing and are linked to hereditary cancer syndromes. Two of the most well-known genetic mutations in cancer are found in the BRCA1 و BRCA2 genes. Mutations found in these genes can lead to an increased risk of breast and ovarian cancers, or less commonly, of prostate and pancreatic cancers. There are additional gene mutations that increase risk for breast, colorectal or prostate cancers (see below for more info on genetic mutations and these cancer types).

Knowing your family health history is a good place to start. Use these tools to gather your family health history and discuss it with your health care provider.

NOTE: This information refers to predictive genetic testing only, which is different from tumor profiling (also known as genomic, biomarker or molecular profiling). Tumor profiling is done after a cancer diagnosis to determine mutations that may affect how the patient responds to certain treatments.

Most cancers are not hereditary—and not everyone with a genetic mutation goes on to develop cancer.

Even if you test negative for these mutations, you can still develop cancer (like anyone!). Most people who have cancer do not have a genetic mutation—only 5%-10% of cancer cases are caused by hereditary gene mutations. Take care to reduce your cancer risk and get the routine cancer screenings you need for better outcomes.

طرق الوقاية من السرطان

أسئلة مكررة

Everything you need to know about genetic testing for cancer risk

If you are adopted or estranged from your family

إذا كنت متبنيًا أو منفصلًا عن عائلتك، فقد تكون معرفتك محدودة أو معدومة بتاريخ عائلتك. تحدث إلى مستشارك الوراثي أو مقدم الرعاية الصحية الخاص بك حول أي تاريخ صحي عائلي تعرفه وعن عرقك/أصلك العرقي لمعرفة ما إذا كان الاختبار الجيني منطقيًا بالنسبة لك. يجب عليك أيضًا دائمًا إبلاغ مقدم الرعاية الصحية الخاص بك إذا تم تبنيك.

Talking to your family

Gene mutations are hereditary and some of your relatives likely share similar or identical risk factors. Please discuss this topic with your family and help make them aware of their options, but understand if they make a different decision than you about genetic testing. It is a decision between each person and their health care providers and genetic counselors. Everyone has the right not to know about their genetic mutations.

سرطان الثدي

Those assigned female at birth who test positive for BRCA1, BRCA2, بالب2 or several other gene mutations are at increased risk for breast or ovarian cancer. Those assigned male at birth who have BRCA2 mutations have an increased risk of breast cancer, and the same is true to a lesser degree for BRCA1 mutations. (Those assigned male at birth with BRCA1 أو BRCA2 mutations are also at increased risk for prostate and pancreatic cancers.) BRCA mutations occur in all races and ethnicities, but one in 40 people of Ashkenazi Jewish descent has a mutation in the BRCA gene.

سرطان قولوني مستقيمي

Those with a personal or family history of colorectal cancer or colon polyps, or a family history of Lynch syndrome (also called hereditary non-polyposis colorectal cancer) or familial adenomatous polyposis (FAP), are at increased risk for colorectal cancer. Genetic mutations associated with Lynch syndrome include MLH1, MSH2, MSH6, PMS2, EPCAM and those associated with FAP include APC.

سرطان البروستات

Those who were assigned male at birth who test positive for BRCA1, BRCA2, HOXB13 or several other gene mutations are at increased risk for prostate cancer. (Those who were assigned male at birth with BRCA1 أو BRCA2 mutations are also at increased risk for breast and pancreatic cancers.) BRCA mutations occur in all races and ethnicities, but one in 40 of those of Ashkenazi Jewish descent has a mutation in the BRCA gene.